Udenafil
- Level
- Commodity
- Parent
- 51413100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51413108This classification denotes a cgmp phosphodiesterase inhibitor, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier L5IB4XLY36. European Medicines Agency schedules Udenafil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32099. Udenafil generally arises in the molecular formula C25H36N6O4S. The term UDENAFIL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 20, no. 1, 2006, list 55.) UDENAFIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.
Same parent
Under 51413100 · 8Activities that produce or sell this
KBLI · 8Inherited from family 51410000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.